tenapanor hydrochloride
tenapanor hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including IBSRELA. Available dosage form: tablet.
Drug Details
- Generic Name
- tenapanor hydrochloride
- Brand Names
- IBSRELA
- Application Number
- NDA211801
- Sponsor
- Patheon Pharmaceuticals Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- TENAPANOR HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults. IBSRELA is a sodium/hydrogen exchanger 3 (NHE3) inhibitor indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults. ( 1 )